A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropathy

Condition:   Diabetic Neuropathy Intervention:   Drug: WST-057 (4% pirenzepine) Lose Dose 2mL Sponsor:   WinSanTor, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials